LianMedical (LIANY)

LianMedical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	103.46	79.22	228.18	254.35	43.3
Short-Term Investments	148.77	223.14	155.07	-	-
Cash & Short-Term Investments	252.22	302.36	383.25	254.35	43.3
Cash Growth	-19.09%	-21.11%	50.68%	487.41%	-
Other Receivables	1.81	4.41	7.22	20.26	-
Receivables	1.81	4.41	7.22	20.26	-
Prepaid Expenses	1.91	4.04	7.68	0.1	-
Other Current Assets	1.86	1.96	1.5	2.04	0.05
Total Current Assets	257.81	312.77	399.65	276.75	43.35
Property, Plant & Equipment	5.01	7.09	6.65	2.53	0.53
Other Long-Term Assets	0.09	0.09	20.05	0.01	-
Total Assets	262.9	319.96	426.34	279.29	43.88

Liabilities

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Accounts Payable	6.23	1.45	3.23	4.33	-
Accrued Expenses	15.88	19.83	9.98	1	0.32
Current Portion of Leases	1.89	1.85	1.13	0.54	0.18
Other Current Liabilities	1.62	0.49	0.76	0.36	2.85
Total Current Liabilities	25.63	23.62	15.09	6.23	3.35
Long-Term Leases	0.95	2.49	3.71	1.34	0.35
Other Long-Term Liabilities	0.21	0.21	20.21	20	-
Total Liabilities	26.79	26.31	39.01	27.57	3.7

Shareholders' Equity

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Common Stock	0	0	0	-	-
Additional Paid-In Capital	745.79	732.48	713.27	31.13	8.52
Retained Earnings	-540.23	-470.53	-360.24	-163.94	-24.33
Comprehensive Income & Other	-3.22	-2.08	0.53	-0.04	-
Total Common Equity	202.34	259.87	353.56	-132.84	-15.82
Minority Interest	33.77	33.77	33.77	34.77	1
Shareholders' Equity	236.11	293.65	387.34	251.72	40.18
Total Liabilities & Equity	262.9	319.96	426.34	279.29	43.88

Additional Metrics

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total Debt	2.84	4.34	4.83	1.88	0.53
Net Cash (Debt)	249.38	298.02	378.42	252.47	42.77
Net Cash Growth	-18.76%	-21.24%	49.89%	490.32%	-
Net Cash Per Share	2.32	2.76	11.00	20.95	8.78
Filing Date Shares Outstanding	108.06	107.16	107.28	20.48	4.87
Total Common Shares Outstanding	107.17	107.04	107.28	20.48	4.87
Working Capital	232.18	289.16	384.56	270.52	40
Book Value Per Share	1.89	2.43	3.30	-6.49	-3.25
Tangible Book Value	202.34	259.87	353.56	-132.84	-15.82
Tangible Book Value Per Share	1.89	2.43	3.30	-6.49	-3.25
Machinery	1.54	1.22	0.54	0.19	-
Construction In Progress	0.05	0.07	1.15	0.02	-
Leasehold Improvements	3.2	3.37	0.81	0.69	-

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2023

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 29, 2026

Data Sources Report a data error